Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: Implications for the 8-aminoquinoline class of anti-malarial compounds
- Sean R. Marcsisin*
- , Jason C. Sousa
- , Gregory A. Reichard
- , Diana Caridha
- , Qiang Zeng
- , Norma Roncal
- , Ronan McNulty
- , Julio Careagabarja
- , Richard J. Sciotti
- , Jason W. Bennett
- , Victor E. Zottig
- , Gregory Deye
- , Qigui Li
- , Lisa Read
- , Mark Hickman
- , N. P.Dhammika Nanayakkara
- , Larry A. Walker
- , Bryan Smith
- , Victor Melendez
- , Brandon S. Pybus
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
72
Scopus
citations